SK Discovery launches bio strategy, investment division
The move will boost cooperation and synergy among the chemical company's bio affiliates
By Dec 06, 2022 (Gmt+09:00)
S.Korea's LS Materials set to boost earnings ahead of IPO process
NPS to commit $1.1 billion to external managers in 2024
Samsung shifts to emergency mode with 6-day work week for executives
Samsung Heavy Industries succeeds autonomous vessel navigation
Korean battery maker SK On expects business turnaround in H2
Korea's chemical company SK Discovery Co. on Tuesday said it launched a bio strategy and investment division headed by Kim Jung-hoon, director of SK Chemicals' R&D center.
The new division will search for new business opportunities for SK Discovery's bio affiliates under the goal of creating horizontal expansion and a synergistic effect through inter-subsidiary collaboration.
A pharmaceutical and bio expert who joined SK Chemicals in 1998 after graduating from the College of Pharmacy at Seoul National University, Kim is experienced in leading overseas business, marketing and R&D organizations at the company.
"SK Discovery's bio affiliates have growth engines thanks to their outstanding human resources and business portfolios," Kim said. "The Bio Strategy and Investment Division will assume a role in fueling each affiliate's growth and creating a synergistic effect."
Write to Jeong Min Nam at peux@hankyung.com
-
Bio & PharmaSK Biopharma's epilepsy treatment posts impressive growth in US
Nov 11, 2022 (Gmt+09:00)
1 Min read -
COVID-19SK Bioscience seeks WHO nod for prompt COVID vaccine sale
Sep 08, 2022 (Gmt+09:00)
1 Min read -
Bio & PharmaSK Discovery to control affiliates’ entire biotechnology business
Aug 05, 2022 (Gmt+09:00)
2 Min read -
Corporate investmentSK takes aim at chips, batteries, bio with $195 billion investment
May 26, 2022 (Gmt+09:00)
3 Min read